Axsome Therapeutics: Settlement Agreement Permits Unichem to Begin Selling Its Generic Version of Sunosi on June 30, 2042, or Earlier Under Certain Circumstances >AXSM
Axsome Therapeutics: Settlement Agreement Permits Unichem to Begin Selling Its Generic Version of Sunosi on June 30, 2042, or Earlier Under Certain Circumstances >AXSM
Axsome therapeutics：和解协议允许Unichem在2042年6月30日或更早在某些情况下开始销售Sunosi的仿制版本>>AXSM
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册